S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AVTE Aerovate Therapeutics Inc

2.42

0.00 (0.00%)

Last Updated: 02:15:26

Delayed by 15 minutes

Form S-4/A - Registration of securities, business combinations: [Amend]

0001104659-25-016402.txt

Aerovate Therapeutics (NASDAQ:AVTE)
Historical Stock Chart
From Jan 2025 to Mar 2025

Click Here for more Aerovate Therapeutics Charts.

Aerovate Therapeutics (NASDAQ:AVTE)
Historical Stock Chart
From Feb 2024 to Mar 2025

Click Here for more Aerovate Therapeutics Charts.

Aerovate Therapeutics Inc News

Form S-4/A - Registration of securities, business combinations: [Amend]
Tuesday 25 February 2025 (4 days ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Tuesday 11 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Saturday 25 January 2025 (1 month ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Form S-4 - Registration of securities, business combinations
Tuesday 3 December 2024 (3 months ago) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Tuesday 26 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Tuesday 19 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm
Saturday 2 November 2024 (4 months ago) • PR Newswire (US)

Form 425 - Prospectuses and communications, business combinations
Friday 1 November 2024 (4 months ago) • Edgar (US Regulatory)

More Aerovate Therapeutics Inc News Articles

BNP Paribas Issuance

Societe Generale Effekten

Invesco Stoxx Europe Sma...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions